Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Clinical trial data delineate activity of pembrolizumab in advanced sarcoma and thyroid cancer

June 14, 2016

FDA awards orphan drug designation to Galena Biopharma's cancer immunotherapy peptide programs

June 13, 2016

Cantargia finalizes tests for CAN-04 before applying for clinical trials

June 13, 2016

Mologen shifts from research to product- and market-oriented company

June 10, 2016

Darvulumab monotherapy shows early evidence of clinical benefit in NSCLC patients

June 10, 2016

Update of clinical trials for cancer vaccine NY-ESO-1(c259) SPEAR T cells given at ASCO

June 9, 2016

First clinical data reported for anti-CD47 monoclonal antibody Hu5F9-G4

June 9, 2016

Enumeral and Pieris sign definitive license agreement

June 9, 2016

TapImmune exercises option agreement to Mayo Clinic HER2/neu vaccine technology

June 8, 2016

Phase II dose selected for checkpoint inhibitor PDR-001 in first-in-human study

June 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.